The Rogue Prince (House of the Dragon)
"The Rogue Prince" is the second episode of the first season of the fantasy drama television series House of the Dragon, a prequel to Game of Thrones.
It received mostly positive reviews, with critics praising its production design, the performances of Milly Alcock and Matt Smith, and the confrontation between Daemon and Rhaenyra at Dragonstone.
Prince-Admiral Craghas Drahar of the Triarchy, an alliance of the Free Cities of Essos, attacks Westerosi ships in the Stepstones regions with his pirate fleet.
Master of Ships Lord Corlys Velaryon demands that the Small Council take action after the Triarchy-backed pirates destroy four Westerosi vessels.
The Small Council learns Daemon, who previously seized Dragonstone, stole the dragon egg that was intended for the late Prince Baelon and has declared his intentions to marry his mistress, Mysaria, who he claims is pregnant, as his second wife.
Insulted by Viserys rejecting his daughter's hand in marriage, Corlys secretly meets with Daemon, and proposes they form an alliance to retake the Stepstones, using the victory to their mutual advantage.
The site's critical consensus said, "Stolen dragon eggs and awkward matchmaking add up to an installment that is designed to lay foundations rather than dazzle in its own right, but 'The Rogue Prince' succeeds in nesting juicy conflicts.
[6] Writing for Rolling Stone, Sean T. Collins summarized the episode with: "Striking imagery, compelling intrigue, humane performances: Put it all together and you've got some damn fine fantasy television.
"[9] Vulture's Hillary Kelly gave it a rating of three out of five and called it, "heavy on exposition and light on fornication," and also praised the confrontation at Dragonstone, saying, "there is finally some delicious, vicious tension in the air.
In the article Dr. Yamni Nigam, professor of health care science at Swansea University, pointed out that maggot therapy has not only been a real-life practice for millennia but has seen a large scale revival in the past 40 years, FDA approved to treat chronic ulcers and other conditions.
